Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

NASDAQ:PHLT - Nasdaq - US71377E1055 - Common Stock - Currency: USD

3.77  -0.02 (-0.53%)

After market: 3.77 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PHLT. PHLT was compared to 103 industry peers in the Health Care Providers & Services industry. While PHLT has a great health rating, there are worries on its profitability. While showing a medium growth rate, PHLT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PHLT has reported negative net income.
PHLT had a positive operating cash flow in the past year.
PHLT had negative earnings in each of the past 5 years.
Of the past 5 years PHLT 4 years had a positive operating cash flow.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of PHLT (-5.66%) is worse than 69.90% of its industry peers.
PHLT's Return On Equity of -7.63% is in line compared to the rest of the industry. PHLT outperforms 41.75% of its industry peers.
Industry RankSector Rank
ROA -5.66%
ROE -7.63%
ROIC N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PHLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

8

2. Health

2.1 Basic Checks

PHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHLT has more shares outstanding than it did 1 year ago.
PHLT has more shares outstanding than it did 5 years ago.
PHLT has a worse debt/assets ratio than last year.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

PHLT has an Altman-Z score of 6.86. This indicates that PHLT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.86, PHLT belongs to the best of the industry, outperforming 90.29% of the companies in the same industry.
The Debt to FCF ratio of PHLT is 1.93, which is an excellent value as it means it would take PHLT, only 1.93 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.93, PHLT belongs to the top of the industry, outperforming 82.52% of the companies in the same industry.
PHLT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
PHLT has a Debt to Equity ratio of 0.10. This is in the better half of the industry: PHLT outperforms 73.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.93
Altman-Z 6.86
ROIC/WACCN/A
WACC9.06%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

PHLT has a Current Ratio of 2.56. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
PHLT has a better Current ratio (2.56) than 86.41% of its industry peers.
PHLT has a Quick Ratio of 2.56. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
PHLT has a Quick ratio of 2.56. This is amongst the best in the industry. PHLT outperforms 86.41% of its industry peers.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 2.56
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PHLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
PHLT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.76%.
Measured over the past years, PHLT shows a decrease in Revenue. The Revenue has been decreasing by -3.95% on average per year.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)11.76%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%21.71%

3.2 Future

Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 70.36% on average per year.
PHLT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.42% yearly.
EPS Next Y111.77%
EPS Next 2Y70.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.38%
Revenue Next 2Y10.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 32.14, which means the current valuation is very expensive for PHLT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHLT is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of PHLT to the average of the S&P500 Index (36.44), we can say PHLT is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 32.14
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

63.11% of the companies in the same industry are cheaper than PHLT, based on the Enterprise Value to EBITDA ratio.
PHLT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 71.09
EV/EBITDA 190.05
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PHLT's earnings are expected to grow with 70.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PHLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (7/21/2025, 8:00:00 PM)

After market: 3.77 0 (0%)

3.77

-0.02 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-12 2025-08-12/amc
Inst Owners81.32%
Inst Owner ChangeN/A
Ins Owners4.48%
Ins Owner Change-5.87%
Market Cap295.23M
Analysts82.22
Price Target7.4 (96.29%)
Short Float %1.57%
Short Ratio5.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.35%
Min EPS beat(2)41.19%
Max EPS beat(2)173.52%
EPS beat(4)4
Avg EPS beat(4)59.56%
Min EPS beat(4)1.96%
Max EPS beat(4)173.52%
EPS beat(8)7
Avg EPS beat(8)75.85%
EPS beat(12)11
Avg EPS beat(12)65.12%
EPS beat(16)14
Avg EPS beat(16)59.12%
Revenue beat(2)1
Avg Revenue beat(2)4.41%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)9%
Revenue beat(4)2
Avg Revenue beat(4)2.21%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)9%
Revenue beat(8)5
Avg Revenue beat(8)1.59%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)10
Avg Revenue beat(16)2.24%
PT rev (1m)3.57%
PT rev (3m)3.57%
EPS NQ rev (1m)35.71%
EPS NQ rev (3m)10.02%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.14
P/S 2.29
P/FCF 71.09
P/OCF 32.95
P/B 3.78
P/tB 9.6
EV/EBITDA 190.05
EPS(TTM)-0.06
EYN/A
EPS(NY)0.12
Fwd EY3.11%
FCF(TTM)0.05
FCFY1.41%
OCF(TTM)0.11
OCFY3.04%
SpS1.65
BVpS1
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.66%
ROE -7.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 3.22%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.93
Debt/EBITDA 5.18
Cap/Depr 72.28%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 580.75%
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 2.56
Altman-Z 6.86
F-Score5
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y111.77%
EPS Next 2Y70.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.76%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%21.71%
Revenue Next Year9.38%
Revenue Next 2Y10.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y199.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2458.16%
OCF growth 3Y88.66%
OCF growth 5YN/A